CVAS, SKYW, and ISTA Update the Investment Community in Exclusive Interviews With WallSt.net
September 26 2005 - 10:23AM
PR Newswire (US)
NEW YORK, Sept. 26 /PRNewswire/ -- On June 24, Sayan Navaratnam,
CEO of Creative Vistas, Inc. (OTC:CVAS) (BULLETIN BOARD: CVAS)
updated the investment community in an all-new, exclusive audio
interview with Wall Street Network. The interview features detailed
discussions on the following topics: * Advantages of the Company's
Iview-360 technology over competing video surveillance solutions *
Contract wins * Marketing and distribution strategy to penetrate
government and commercial sectors * Current cash position * Recent
acquisitions * Intellectual property * Upcoming operational and
financial milestones To hear the interview in its entirety, and to
read an in-depth report about Creative Vistas, visit
http://wallst.net/superstock/CVAS/cvas.html On September 22,
Michael Kraupp, VP of Finance for SkyWest, Inc. (NASDAQ:SKYW)
updated the investment community in an all-new, exclusive interview
with Wall Street Network. Interview highlights include detailed
discussions on the following topics: -- operating model that hedges
against downward economic cycles -- maintaining profitability in
the airline industry -- possible growth opportunities resulting
from Delta's recent filing for Chapter 11 -- financial integration
of Atlantic Southeast Airlines (ASA) -- increases in traffic --
expansion of operations from the ASA acquisition -- why SkyWest is
a good investment in the airline industry -- upcoming operational
and financial milestones On September 22, Lauren Silvernail, VP of
Corporate Development and Chief Financial Officer for ISTA
Pharmaceuticals, Inc. (NASDAQ:ISTA) updated the investment
community in an all-new, exclusive interview with Wall Street
Network. Interview highlights include detailed discussions on the
following topics: -- overview of the Company, and its target
markets -- in-depth discussion on Vitrase, what it does, and how it
can improve current procedures -- launch of Xibrom, details about
the anti-inflammation treatment, and markets for the product --
timeline for revenue ramp-up -- upcoming strategic and financial
milestones To hear the interviews in their entirety, visit
http://www.wallst.net/ . The interviews can be accessed by locating
the respective company's ticker symbol under the appropriate
exchange on the left-hand column of the homepage, or by entering
the respective company's ticker symbol in the Audio Search window.
About Wall Street Network Wall Street Network is owned and licensed
by Wall Street Direct, Inc. All material herein was prepared by
Digital Wall Street, Inc., a multimedia provider of original,
insightful commentary and news from North America's leading
publicly traded companies giving a direct link to the management of
today's fastest-growing companies through encompassing executive
interviews and sector seminars. Digital Wall Street, Inc. has
received sixteen-thousand- five hundred dollars from the company,
and six thousand five hundred free trading shares of CVAS from a
third party for press and advertising services. Digital Wall
Street, Inc. intends to purchase up to twenty thousand shares of
CVAS in the open market, and has received an additional two hundred
thousand restricted shares of CVAS from the company for press and
advertising services. For a complete list of our business
relationships, visit http://www.wallst.net/disclaimer.asp .
Contact: Nick Iyer Digital Wall Street, Inc. 800-4-WALL-ST
DATASOURCE: Wall Street Network CONTACT: Nick Iyer of Digital Wall
Street, Inc., +1-800-4-WALL-ST Web site:
http://wallst.net/superstock/CVAS/cvas.html Web site:
http://www.wallst.net/
Copyright